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Abstract 
 
Background: When selecting predictive tools, clinicians and healthcare professionals 
are challenged with an overwhelming number of tools, most of which have never been 
evaluated for comparative effectiveness. To overcome this challenge, the authors 
developed and validated an evidence-based framework for grading and assessment of 
predictive tools (GRASP), based on the critical appraisal of published evidence. 
 
Methods: To examine GRASP impact on professionals’ decisions, a controlled 
experiment was conducted through an online survey. Randomising two groups of tools 
and two scenarios; participants were asked to select the best tools; most validated or 
implemented, with and without GRASP. A wide group of international participants were 
invited. Task completion time, rate of correct decisions, rate of objective vs subjective 
decisions, and level of decisional conflict were measured. 
 
Results: Valid responses received were 194. Compared to not using the framework, 
GRASP significantly increased correct decisions by 64% (T=8.53, p<0.001), increased 
objective decision making by 32% (T=9.24, p<0.001), and decreased subjective decision 
making; based on guessing and based on prior knowledge or experience by 20% (T=-
5.47, p<0.001) and 8% (T=-2.99, p=0.003) respectively. GRASP significantly decreased 
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decisional conflict; increasing confidence and satisfaction of participants with their 
decisions by 11% (T=4.27, p<0.001) and 13% (T=4.89, p<0.001) respectively. GRASP 
decreased task completion time by 52% (T=-0.87, p=0.384). The average system usability 
scale of GRASP was very good; 72.5%, and 88% of participants found GRASP useful. 
 
Discussion and Conclusions: Using GRASP has positively supported and significantly 
improved evidence-based decision making and increased accuracy and efficiency of 
selecting predictive tools. GRASP represents a high-level approach and an effective, 
evidence-based, and comprehensive, yet simple and feasible, method to evaluate, 
compare, and select clinical predictive tools. 
 
 
Keywords: Clinical Prediction, Clinical Decision Support, Grading and Assessment, 
Evidence-Based, Impact Evaluation. 
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1. Background 
 
Clinical decision support (CDS) systems have been proved to enhance evidence-
based practice and support cost-effectiveness [1-6]. Based on Shortliffe’s three levels 
classification, clinical predictive tools, here referred to simply as predictive tools, 
belong to the highest CDS level; providing patient-specific recommendations based on 
clinical scenarios, which usually follow clinical rules and algorithms, cost benefit 
analysis, or clinical pathways [7, 8]. Such tools include various applications; ranging 
from the simplest manual clinical prediction rules to the most sophisticated machine 
learning algorithms [9, 10]. These research-based applications provide diagnostic, 
prognostic, or therapeutic decision support. They quantify the contributions of relevant 
patient characteristics to derive the likelihood of diseases, predict their courses and 
possible outcomes, or support the decision making on their management [11, 12]. 
 
When selecting predictive tools for implementation at the clinical practice or for 
recommendation in clinical guidelines; clinicians and healthcare professionals, here 
referred to simply as "Professionals”, involved in the decision making, are challenged 
with an overwhelming and ever-growing number of tools. Many of these have never 
been implemented or evaluated for comparative effectiveness [13-15]. By definition, 
healthcare professionals include all clinicians who provide direct care to patients, in 
addition to professionals who work in laboratories, researchers, and public health 
experts [16]. Professionals usually rely on previous experience, subjective evaluation or 
recent exposure to predictive tools in making selection decisions. Objective methods 
and evidence-based approaches are rarely used in such decisions [17, 18].  
 
When developing clinical guidelines, some professionals search the literature for 
studies that describe development, implementation or evaluation of predictive tools. 
Others look for systematic reviews comparing tools’ performance or development 
methods. However, there are no available approaches to objectively summarise or 
interpret such evidence [19, 20]. In addition, predictive tools selection decisions are 
time consuming; seeking a consensus of subjective expert views [21]. Furthermore, 
when experts make their decisions subjectively they face much decisional conflict; 
being less confident in the decisions they make and sometimes less satisfied with them 
[22]. 
 
To overcome this major challenge, the authors have developed and validated a 
new evidence-based framework for grading and assessment of predictive tools (The 
GRASP Framework) [23]. The aim of this framework is to provide standardised objective 
information on predictive tools to support the search for and selection of effective 
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tools. Based on the critical appraisal of published evidence, GRASP uses three 
dimensions to grade predictive tools: 1) Phase of Evaluation, 2) Level of Evidence and 
3) Direction of Evidence. 
 
Phase of Evaluation: Assigns A, B, or C based on the highest phase of evaluation. 
If a tool’s predictive performance, as reported in the literature, has been tested for 
validity, it is assigned phase C. If a tool’s usability and/or potential effect have been 
tested, it is assigned phase B. Finally, if a tool has been implemented in the clinical 
practice, and there is published evidence evaluating its post-implementation impact, it 
is assigned phase A. 
  
Level of Evidence: A numerical score, within each phase, is assigned based on 
the level of evidence associated with each tool. A tool is assigned grade C1 if it has been 
tested for external validity multiple times, grade C2 if it has been tested for external 
validity only once, and grade C3 if it has been tested only for internal validity. Grade C0 
means that the tool did not show sufficient internal validity to be used in the clinical 
practice. Grade B1 is assigned to a predictive tool that has been evaluated, during the 
planning for implementation, for both of its potential effect, on clinical effectiveness, 
patient safety or healthcare efficiency, and for its usability. Grade B2 is assigned to a 
predictive tool that has been evaluated only for its potential effect, while if it has been 
studied only for its usability, it is assigned grade B3. Finally, if a predictive tool had 
been implemented then evaluated for its post-implementation impact, on clinical 
effectiveness, patient safety or healthcare efficiency, then it is assigned grade A1 if 
there is at least one experimental study of good quality evaluating its post-
implementation impact, grade A2 if there are observational studies evaluating its 
impact, and grade A3 if the post-implementation impact has been evaluated only 
through subjective studies, such as expert panel reports. 
 
Direction of Evidence: For each phase and level of evidence, a direction of 
evidence is assigned based on the collective conclusions reported in the studies. The 
evidence is considered positive if all studies about a predictive tool reported positive 
conclusions and negative if all studies reported negative or equivocal conclusions. The 
evidence is considered mixed if some studies reported positive and some reported 
either negative or equivocal conclusions. To decide an overall direction of evidence, a 
protocol is used to sort the mixed evidence into supporting an overall positive or 
negative conclusion. The protocol is based on two main criteria; 1) Degree of matching 
between the evaluation study conditions and the original tool specifications, and 2) 
Quality of the evaluation study. Studies evaluating tools in closely matching conditions 
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to the tools’ specifications and providing high quality evidence are considered first for 
their conclusions in deciding the overall direction of evidence. 
 
The final grade assigned to a tool is based on the highest phase of evaluation, 
supported by the highest level of positive evidence, or mixed evidence that supports a 
positive conclusion. The GRASP framework concept is shown in Figure 1 and the GRASP 
framework detailed report is presented in Table 3 in the Appendix. 
 
Medium Evidence – Tested for External Validity Only Once
High Evidence – Tested for External Validity Multiple Times
Reported Usability Testing
Reported Potential Effect on Healthcare
Both Potential Effect & Usability
Based on Subjective Studies
Observational Studies
Experimental Studies
Clinical 
Effectiveness, 
Patient Safety, or
A1
Phase A: Post
Implementation
Impact
Phase B: 
Planning for
Implementation
Phase C: Pre
Implementation 
Performance
A2
A3
B1
B2
Assigned 
Grades
C1
C2
C3
GRASP Framework – Grading and 
Assessment of Predictive Tools 
for Clinical Decision Support
Healthcare Efficiency
Direction of 
Evidence
Positive
Negative
Mixed supporting 
positive conclusion
Mixed supporting 
negative conclusion
Phase of Evaluation
Level of 
Evidence
Low Evidence – The Tool Has Been Tested for Internal Validity
B3
Figure 1: The GRASP Framework Concept [23] 
 
The aim of this study is to evaluate the impact of using GRASP on the decisions 
made by professionals in selecting predictive tools for clinical decision support. The 
objective is to explore whether the GRASP framework is going to positively support 
professionals’ evidence-based decision-making and improve their accuracy and 
efficiency in selecting clinical predictive tools. To explore this impact, a group of 
hypotheses have been proposed including that; using the GRASP framework by 
professionals is going to 1) Make their decisions more accurate, i.e. selecting the best 
predictive tools. 2) Make their decisions more objective, informed, and evidence-based, 
i.e. decisions are based on the information provided by the framework. 3) Make their 
decisions less subjective, i.e. decisions are less based on guessing, prior knowledge, or 
experience. 4) Make their decisions more efficient, i.e. decisions are made in less time. 
5) Make them face less decisional conflict, i.e. become more confident in their decisions 
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and more satisfied with them. We also propose that using GRASP can move 
professionals who have less knowledge, less experience, and are less familiar with 
predictive tools to an equal or even higher accuracy of decision making than 
professionals who have more knowledge, more experience, and are more familiar with 
tools, when they do not use GRASP. 
 
2. Methods 
 
2.1. The Study Design 
 
This study is based on experimental methods. It aims at examining the 
performance and outcomes of professionals’ decisions in selecting predictive tools with 
and without using the GRASP framework. Through an online survey, the experiment 
involves asking participants to select the best predictive tool, for implementation at the 
clinical practice or for recommendation in clinical practice guidelines, from a group of 
five similar tools doing the same predictive task, one time with and another time 
without using the GRASP framework. In addition, participants are asked a few questions 
regarding the process of making their decisions through the two scenarios. Participants 
are also requested to provide their feedback on the perceived usability and usefulness 
of the evidence-based summary of the GRASP framework. 
 
The emergency department (ED) is among the top healthcare specialties that are 
increasingly utilising predictive tools especially in the area of managing traumatic brain 
injury (TBI), being the leading cause of death and disability among trauma patients [24-
27]. Two groups of predictive tools designed to exclude TBI in ED were prepared. The 
first group includes five tools for predicting TBI in paediatrics; PECARN – Paediatric 
Emergency Care Applied Research Network head injury rule, CHALICE – Children's Head 
injury ALgorithm for the prediction of Important Clinical Events, CATCH – Canadian 
Assessment of Tomography for Childhood Head injury rule, Palchak head injury rule, 
and Atabaki head injury rule [28-32].  
 
The PECARN is the best tool among the five; being the most validated and the 
only tool that has been implemented in clinical practice and proved to have positive 
post-implementation impact [33, 34]. The second group includes five tools for 
predicting TBI in adults; CCHR – Canadian CT Head Rule, NOC – New Orleans Criteria, 
Miller criteria for head computed tomography, KHR – Kimberley Hospital Rule, and 
Ibanez model for head computed tomography [35-39]. The CCHR and NOC are the best 
tools among the five; being the only tools that have been implemented in clinical 
practice and are the most validated, showing high predictive performance [40-42].  
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Two scenarios were prepared for this experiment. The first is the control 
scenario, which includes providing participants with the basic information about each 
tool, the full text of the original studies describing the tools, in addition to allowing 
them to search the internet for information. The second is the experiment scenario, 
which includes providing participants with the main component of the GRASP 
framework, which is the evidence-based summary on the predictive tools, the full 
GRASP report on each tool, in addition to allowing them to search the internet for 
information.  
 
To minimise bias, eliminate pre-exposure effect, and improve the robustness, the 
experiment includes randomising the two groups of predictive tools and the two 
scenarios. Accordingly, participants go randomly through one of four scenarios; 1) 
Paediatric Tools without GRASP then Adult Tools with GRASP, 2) Paediatric Tools with 
GRASP then Adult Tools without GRASP, 3) Adult Tools without GRASP then Paediatric 
Tools with GRASP, 4) Adult Tools with GRASP then Paediatric Tools without GRASP. 
Figure 2 shows the survey workflow and the randomisation. 
 
The authors recruited a wide group of international professionals to participate 
in this experiment through an online survey. To identify potential participants who 
work at the emergency department and those who have knowledge or experience about 
CDS tools, published studies were used to retrieve the authors’ emails and invite them. 
Four databases were used; MEDLINE, EMBASE, CINAHL, and Google Scholar to retrieve 
studies on CDS systems, tools, models, algorithms, pathways, or rules used in the 
emergency department, emergency service, or emergency medicine published over the 
last five years by professionals who work in the emergency departments or services of 
their healthcare organisations or those who conducted emergency medicine, emergency 
department, or emergency services research.  
 
The authors expected the response rate to be around 10%. Before the deployment 
of the survey a pilot testing, by ten expert professionals, was conducted. The feedback 
of the pilot testing was used to improve the survey. Professionals who participated in 
the pilot testing were excluded from the participation in the final survey. An invitation 
email, introducing details about the study objectives, the GRASP framework, the 
experiment task, the survey completion time, which was estimated at 20 minutes, and a 
participation consent, was submitted to the identified potential participants with the 
link to the online survey. A reminder email, in two weeks, was sent to the potential 
participants who did not respond or complete the survey. 
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2.2. The Study Survey 
 
The online survey was developed using Qualtrics Experience Management 
Solutions Platform [43]. The survey, illustrated through screenshots in the Appendix, 
includes five sections. The first section includes an introduction about the study 
objectives, the GRASP framework and the experiment task. In addition, participants are 
provided with contacts for requesting further information or submitting complaints. 
The second section includes randomising the two scenarios and the two groups of 
predictive tools, to create the four scenarios described above. 
 
Start Survey
Introduction
Randomisation
Scenario 1 Scenario 2 Scenario 3 Scenario 4
Adult Tools 
(with GRASP) Adult Tools 
(without GRASP)
Paediatric Tools 
(with GRASP) Paediatric Tools 
(without GRASP)
Demographic Information
End of Survey
Feedback & Acknowledgment
Paediatric Tools 
(without GRASP)
Paediatric Tools 
(with GRASP) Adult Tools 
(without GRASP)
Adult Tools 
(with GRASP)
SUS & Usefulness
SUS & Usefulness
SUS & Usefulness
SUS & Usefulness
 
Figure 2: Survey Workflow and Randomisation of the Four Scenarios 
 
In this second section, participants are asked to assume that they are the heads 
of busy emergency departments and they are responsible for selecting the best tool; the 
most validated in the literature or implemented in the clinical practice, out of five 
diagnostic head injury predictive tools. The PECARN is the correct answer among the 
five paediatric tools and both the CCHR and the NOC are correct answers among the five 
adult tools. On a five-point Likert scale, participants are asked to show how much they 
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agree that; 1) they made their decisions based on guessing, 2) they made their decisions 
based on prior knowledge or experience, 3) they made their decisions based on the 
information provided in the survey, 4) they are confident in their decisions, and 5) they 
are satisfied with their decisions. The third section includes asking participants to 
provide their feedback on the usability of the evidence-based summary of the GRASP 
framework, through a standard set of System Usability Scale (SUS) questions [44, 45]. 
Participants were also asked to provide a free-text feedback on whether they think the 
framework is usefulness or not and why they think so. The fourth section includes 
participants’ demographics, such as their clinical or healthcare role, specialty, gender, 
age group, years of experience, and how much they are familiar with head injury 
predictive tools. 
 
2.3. The Study Sample Size 
 
Based on similar studies, evaluating the impact of using information systems on 
professionals’ objective, informed, and evidence-based decisions, the authors aimed to 
recruit a sample of 40 to 60 participants [46-48]. It was estimated that a sample size of 
46 participants would be sufficient to test for differences in the measured outcomes 
when using a paired t-test with a significance level of 0.05 and power of 0.95. 
Calculations were conducted using G*Power version 3.1.9.2 [49]. 
 
2.4. Analysis and Outcomes 
 
To test the five proposed hypotheses, the study was designed to compare the 
two scenarios; making decisions with and without using the GRASP framework, based on 
a group of seven measures. 1) Time needed for tools’ selection decision making. 2) 
Accuracy of tools’ selection decisions. 3) Making decisions subjectively based on 
guessing. 4) Making decisions subjectively based on prior knowledge and/or experience. 
5) Making decisions objectively based on the information and evidence provided. 6) 
Levels of participants’ confidence in their decisions. 7) Levels of participants’ 
satisfaction with their decisions. The accuracy of making decisions, with and without 
GRASP, will also be compared along knowledge, experience, and familiarity with 
predictive tools. To avoid inflated Type I error and account for the five tested 
hypotheses, and the seven compared measures, the Bonferroni correction was used, 
through setting the alpha value of the paired samples t-test to 0.007 instead of 0.05. 
The sample size is re-estimated to 96 participants. In addition, the SUS was calculated 
for the average rate and the distribution of scores. The perceived usefulness and the 
free-text feedback were analysed. The demographic variables were analysed for possible 
correlations or differences. 
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3. Results 
 
3.1. Descriptive Analysis 
 
Out of 5,857 relevant publications retrieved, a total of 3,282 professionals were 
identified and invited to take the survey. Over the survey duration of six weeks, from 11 
March to 21 April 2019, a total of 194 valid responses were received, with a response 
rate of 5.9%. Valid responses were identified as those who completed the survey till the 
end and answered questions in all the survey sections, with no missing sections. Six 
participants missed answering one or more questions in one or more of the survey 
sections, five participants did not provide their demographics, and fifty-seven 
participants did not wish to be acknowledged in the study. The detailed distributions of 
participants based on gender, age group, years of experience, clinical and healthcare 
role, clinical specialty, familiarity with head injury predictive tools, and their countries 
are reported in the Appendix, in Tables 7 to 13 and illustrated in Figures 3 to 9. 
 
3.2. The GRASP Impact on Participants’ Decisions 
 
Using the GRASP framework; the evidence-based summary of predictive tools, the 
detailed report on each predictive tool, in addition to allowing participants to search the 
Internet, made them select the correct tools 88.1% of the time. Without GRASP; i.e. using 
the basic information about the predictive tools, the full text of the studies describing 
each tool, in addition to allowing participants to search the Internet, they selected the 
correct tools 53.7% of the time. This shows a statistically significant improvement of 
64% (P<0.001). On a five-point Likert scale, where strongly agree is considered equal to 
five and strongly disagree is considered equal to one, the participants reported they 
made their tools’ selection decisions based on guessing with an average of 1.98 when 
they used GRASP, compared to an average of 2.48 when they did not use GRASP. This 
shows a statistically significant reduction of 20% (P<0.001). Participants reported that 
they made their tools’ selection decisions based on their prior knowledge and/or 
experience with an average of 3.27 when they used GRASP, compared to an average of 
3.55 when they did not use GRASP. This shows a statistically significant reduction of 8% 
(P=0.0035). 
 
Participants reported that they made their tools’ selection decisions based on the 
provided information in the survey with an average of 4.10 when they used GRASP, 
compared to an average of 3.11 when they did not use GRASP. This shows a statistically 
significant increase of 32% (P<0.001). Participants reported that they were confident in 
   11 
their decisions with an average of 3.96 when they used GRASP, compared to an average 
of 3.55 when they did not use GRASP. This shows a statistically significant increase of 
11% (P<0.001). Participants reported that they were satisfied with their decisions with an 
average of 3.99 when they used GRASP, compared to an average of 3.54 when they did 
not use GRASP. This shows a statistically significant increase of 13% (P<0.001). The 
duration of completing the task of selecting predictive tools showed high variability, 
with many statistical outliers. In addition to the average, the authors used the 
percentiles to avoid the effect of extreme outliers. The average duration of making the 
selection decisions showed a statistically insignificant reduction of 52% from 14.5 to 7.0 
minutes (p= 0.385). There is also a reduction of 18.9% from 2.2 to 1.8 minutes on the 
50
th
 percentile, 37.3% from 5.3 to 3.3 minutes on the 75
th
 percentile, 48.0% from 12.4 to 
6.4 minutes on the 90
th
 percentile, and 30.6% from 19.2 to 13.3 minutes on the 95
th
 
percentile. Table 1 shows the impact of using GRASP on the seven measures; decision 
accuracy, guessing, subjective decisions, objective decisions, confidence in decisions, 
satisfaction with decisions, and task completion duration 90
th
 percentile in minutes.  
 
Table 1: The Impact of Using GRASP on Participants’ Decisions 
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All Participants (n=194) 
No GRASP 53.7% 2.48 3.55 3.11 3.55 3.54 12.4 
GRASP 88.1% 1.98 3.27 4.10 3.96 3.99 6.4 
Change 64% -20% -8% 32% 11% 13% -48% 
P-value <0.0001 <0.0001 0.0032 <0.0001 <0.0001 <0.0001 0.3848 
 
Using paired-samples t-test, Table 2 shows the estimation for paired difference 
of the seven measures and the effect size, calculating and interpreting the eta squared 
statistic, based on the guidelines propose by Cohen 2013 [50]. 
 
Table 2: Estimation for Paired Difference and Effect Size 
Measure Mean St Dev SE Mean 99.3% CI
 1
 T-Value P-Value Effect Size
 2
 
Score 0.340 0.555 0.040 (0.231, 0.449) 8.53 <0.0001 0.274 Large 
Guessing -0.519 1.303 0.095 (-0.777, -0.260) -5.47 <0.0001 0.134 Moderate 
Subjective -0.319 1.464 0.107 (-0.613, -0.028) -2.99 0.0032 0.044 Small 
Objective 1.005 1.496 0.109 (0.709, 1.302) 9.24 <0.0001 0.307 Large 
Confidence 0.392 1.261 0.092 (0.141, 0.642) 4.27 <0.0001 0.086 Moderate 
Satisfaction 0.439 1.235 0.090 (0.194, 0.684) 4.89 <0.0001 0.110 Moderate  
Duration
 3
 -447 7152 514 (-1847, 952) -0.87 0.3848 Not Applicable 
1 
Bonferroni correction conducted.  
2 
Effect size calculated using eta squared statistic (0.01=small effect, 0.06=moderate effect, and 0.14=large effect [50]) 
3 
Task completion duration is reported in seconds. 
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Table 3 compares physicians to non-physicians, emergency medicine to other 
specialties, familiar with tools to non-familiar, males to females, younger to older and 
less experienced to more experienced participants. The GRASP detailed report is shown 
in Table 4 in the Appendix. The GRASP evidence-based summaries of the two groups of 
paediatric and adult predictive tools are shown in Tables 5 and 6 in the Appendix. 
 
Table 3: Comparing the Impact of GRASP on Participants’ Groups 
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Role 
Physicians 
(n=130) 
No GRASP 61.4% 2.4 3.7 3.0 3.6 3.6 10.9 
GRASP 89.0% 2.0 3.5 4.0 4.0 4.0 6.1 
Change 45% -18% -5% 33% 10% 12% -44% 
P-value 0.000 0.000 0.080 0.000 0.001 0.000 0.620 
Non-
Physicians 
(n=59) 
No GRASP 37.3% 2.7 3.3 3.5 3.5 3.5 15.3 
GRASP 84.7% 2.0 2.8 4.4 3.8 3.9 6.6 
Change 127% -25% -16% 28% 10% 14% -57% 
P-value 0.000 0.000 0.007 0.000 0.047 0.008 0.263 
Specialty 
Emergency 
(n=94) 
No GRASP 72.5% 2.4 4.1 2.8 3.8 3.8 11.0 
GRASP 93.4% 1.9 3.7 3.8 4.1 4.1 6.5 
Change 29% -19% -10% 36% 6% 7% -41% 
P-value 0.000 0.000 0.009 0.000 0.066 0.041 0.512 
Non-
Emergency 
(n=95) 
No GRASP 36.2% 2.6 3.0 3.4 3.3 3.2 15.0 
GRASP 83.0% 2.0 2.9 4.4 3.8 3.8 6.5 
Change 129% -21% -6% 28% 15% 19% -57% 
P-value 0.000 0.000 0.096 0.000 0.001 0.000 0.109 
Familiarity 
with tools 
Familiar 
(n=108) 
No GRASP 67.0% 2.3 4.1 2.8 3.8 3.8 8.1 
GRASP 89.6% 1.8 3.7 3.8 4.1 4.1 5.3 
Change 34.0% -22.0% -10.0% 39.0% 8.0% 8.0% -34.0% 
P-value 0.000 0.000 0.007 0.000 0.016 0.013 0.512 
Not Familiar 
(n=81) 
No GRASP 36.3% 2.7 2.8 3.6 3.3 3.2 18.2 
GRASP 85.0% 2.2 2.7 4.5 3.7 3.8 7.9 
Change 134% -18% -5% 23% 14% 19% -57% 
P-value 0.000 0.002 0.155 0.000 0.003 0.000 0.237 
Gender 
Males (n=120) 
No GRASP 54.2% 2.3 3.5 3.1 3.7 3.6 13.5 
GRASP 82.2% 2.0 3.3 4.1 3.9 4.0 7.4 
Change 52% -14% -7% 33% 8% 10% -45% 
P-value 0.000 0.005 0.081 0.000 0.009 0.002 0.408 
Females 
(n=67) 
No GRASP 54.5% 2.9 3.5 3.3 3.3 3.4 12.2 
GRASP 97.0% 2.0 3.1 4.3 3.9 4.0 5.3 
Change 78% -30% -12% 29% 17% 18% -56% 
P-value 0.000 0.000 0.004 0.000 0.004 0.001 0.536 
Age 
Younger (<45 
Years, n=112) 
No GRASP 58.7% 2.6 3.6 3.1 3.5 3.5 9.1 
GRASP 87.2% 2.0 3.3 4.1 4.0 4.0 6.0 
Change 48% -25% -7% 34% 13% 14% -34% 
P-value 0.000 0.000 0.057 0.000 0.001 0.001 0.446 
Older (>45 
Years, n=77) 
No GRASP 46.8% 2.3 3.5 3.2 3.6 3.6 15.9 
GRASP 88.3% 2.0 3.2 4.1 3.9 4.0 7.7 
Change 89% -13% -10% 28% 7% 10% -52% 
P-value 0.000 0.032 0.009 0.000 0.080 0.004 0.188 
Experience 
Less 
Experience 
(<15 Years, n= 
94) 
No GRASP 58.7% 2.6 3.6 3.0 3.5 3.4 8.1 
GRASP 87.0% 2.0 3.3 4.0 3.9 4.0 6.5 
Change 48% -24% -7% 36% 12% 16% -20% 
P-value 0.000 0.000 0.090 0.000 0.009 0.001 0.460 
More 
Experience 
(>15 Years, 
n=95) 
No GRASP 48.9% 2.4 3.5 3.3 3.6 3.6 15.0 
GRASP 88.3% 2.0 3.2 4.2 3.9 4.0 6.8 
Change 80% -16% -10% 28% 9% 9% -54% 
P-value 0.000 0.004 0.006 0.000 0.004 0.004 0.111 
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3.3. The GRASP Usability and Usefulness 
 
The overall SUS rate of the GRASP framework and evidence-based summary, 
considering the responses of all 194 participants, was 72.5%, which represents a very 
good level of usability [51, 52]. Examining the influence of demographics on the SUS 
rates, only two factors showed significant influence; the gender of participants and their 
familiarity with predictive tools. Female participants reported a statistically significant 
higher SUS rate; 76.2%, compared to male participants; 70.8%, showing that female 
participants thought GRASP is easy to use more than male participants. Using statistical 
Spearman’s correlation test; the degree of familiarity with head injury predictive tools 
showed a weak negative statistically significant correlation with the GRASP SUS score 
(p=0.031). This indicates that participants who were less familiar with predictive tools 
thought that the GRASP framework was easy to use more than participants who were 
more familiar with the tools. 
 
Among the 194 valid responses of participants, almost two thirds; 122, provided 
a free-text feedback on the GRASP evidence-based summary usefulness and explained 
their feedback. Most participants, 88%, reported that they found the GRASP evidence-
based summary useful. They explained their responses by various reasons; mainly that 
the evidence-based summary was simple, clear and logic. Some reported that the visual 
presentation was attractive, intuitive, and self-explanatory. Others reported that it 
provided a summary of much information in a concise and comprehensive way and 
some reported that the presented information was consistent, easily comparable, 
making informed decisions easier.  
 
A smaller group of 12% of participants reported that they found the GRASP 
evidence-based summary not useful. They reported that it did not provide enough 
information to make informed decisions. Some reported that it was not clear enough, or 
simple enough, to understand and use to select predictive tools. One healthcare 
professional reported that “It is too complicated and needs to be simplified further”, 
while another reported that “It is oversimplified and missing some important 
parameters”. One healthcare professional reported “It might be more helpful when the 
decision is less clear” and added “I would like to see more info on the 
strengths/weaknesses of each tool”. 
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4. Discussion and Conclusion  
 
4.1. Brief Summary 
 
It is a challenging task for most professionals to critically evaluate a growing 
number of predictive tools, proposed in the literature, in order to select effective tools 
for implementation at the clinical practice or for recommendation in clinical guidelines. 
Although most of these predictive tools have been assessed for predictive performance, 
only a few have been implemented and evaluated for comparative effectiveness or post-
implementation impact. Professionals need an evidence-based approach to provide 
them with standardised objective information on predictive tools to support their 
search for and selection of effective tools for the clinical tasks. Based on the critical 
appraisal of the published evidence, the GRASP framework uses three dimensions to 
grade predictive tools: 1) Phase of Evaluation, 2) Level of Evidence and 3) Direction of 
Evidence. The final grade assigned to a tool is based on the highest phase of evaluation, 
supported by the highest level of positive evidence, or mixed evidence that supports a 
positive conclusion. In this manuscript, we present an evaluation of the impact of the 
GRASP framework on professionals’ decisions in selecting predictive tools for clinical 
decision support. 
 
4.2. The GRASP Impact on Participants’ Decisions 
 
The GRASP framework provides a systematic and transparent approach for 
professionals to make objective, well informed, and evidence-based decisions regarding 
selecting predictive tools. This is very similar to the findings of using the GRADE 
framework (Grading of Recommendations Assessment, Development and Evaluation) in 
evaluating the quality of evidence and strength of recommendations regarding 
treatment methods and decisions endorsed in clinical guidelines [53, 54]. The quality of 
decision making, while developing clinical guidelines, depends significantly on the 
quality of evidence-informed analysis and advice provided [55]. Similarly, supporting 
professionals with evidence improves their accuracy and help them make better clinical 
decisions as well as better organisational decisions [56, 57]. Likewise, using GRASP, and 
providing professionals with evidence-based information on predictive tools, 
significantly improved professionals’ accuracy of decisions in selecting the best 
predictive tools.  
 
Providing professionals with GRASP evidence-based information also enabled 
them to minimise subjective decision making, such as guessing, prior knowledge or 
previous experience. This has been proved in other studies discussing the role of 
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utilising evidence-based resources in decreasing subjective bias in making clinical, 
population, and health policy decisions [58, 59]. Evidence-based information of GRASP 
proved also to decrease professionals’ decisional conflict, through increasing their 
confidence in their decisions and their satisfaction with them. This has been proved in 
similar studies discussing the impact of evidence-based information on decreasing 
decisional conflicts faced by both professionals and patients when they make clinical 
decisions [60-62]. When time is a sensitive factor for critical clinical and population 
decisions, efficient decision making becomes important [63]. Here comes the role of 
evidence-based decision making, which proved to be not only more accurate, objective 
and of higher quality, but also much more efficient [64, 65]. Similarly, providing 
professionals with GRASP evidence-based information improved their efficiency in 
making predictive tools’ selection decisions. 
 
Using GRASP made nurses and other professionals make more accurate decisions 
than physicians, when they were not using GRASP. Using GRASP, clinicians of specialties 
other than emergency medicine made better decisions than emergency medicine 
clinicians without GRASP. Furthermore, using GRASP, professionals who were not 
familiar with head injury predictive tools made better decisions than professionals who 
were familiar with the tools without GRASP. Furthermore, using GRASP made decisions 
more efficient. Accordingly, using GRASP has moved professionals with less knowledge, 
less experience, and less familiarity with predictive tools to higher accuracy, higher 
efficiency, and better decision-making levels than professionals who had more 
knowledge, more experience, and were more familiar with tools, but were not using 
GRASP. 
 
4.3. The GRASP Usability and Usefulness 
 
The usability of systems is an important foundation of their successful 
implementation and utilisation [66]. Usability can be evaluated through measuring the 
effectiveness of task management with accuracy and completeness, measuring 
efficiency of utilising resources in completing tasks and measuring users’ satisfaction, 
comfort with, and positive attitudes towards, the use of the tools [67, 68]. One of the 
validated and simply applicable methods of measuring usability is the SUS [44, 45]. 
When users have more experience with a system they tend to provide higher, more 
favourable SUS scores for the system usability over users with either no or limited 
experience [69]. On the other hand, when users have less experience with a system, they 
tend to see new tools illustrating the system, or new approaches to understand it, more 
usable than users who have extensive experience with the system itself [70]. This 
explains why the degree of familiarity with the tools was negatively correlated with the 
   16 
GRASP SUS score, where participants less familiar with tools provided higher SUS scores 
for GRASP than participants who were more familiar. It is reported in the literature that 
gender has no influence on the perceived usability or usefulness of systems [71, 72]. 
This was not the case with GRASP, where female participants provided higher SUS scores 
than males. Furthermore, female participants also thought GRASP is useful more than 
males. Both findings could be explained by the greater improvement in female 
participants’ confidence and satisfaction with their decisions, when they used GRASP, 
compared to male participants. Some participants’ suggestions, reported in the free-text 
feedback, can be used in the future to add more information to the GRASP detailed 
report on each tool. 
 
4.4. Study Conclusion 
 
Through this study, the GRASP framework proved to be an effective evidence-
based approach to support professionals’ decisions when selecting predictive tools for 
implementation at the clinical practice or for recommendation in clinical guidelines. 
Using the GRASP framework and the evidence-based summary improved the accuracy of 
selecting the best predictive tools, with an increased objective, informed, and evidence-
based decision making, and decreased subjective decision making; based on guessing, 
prior knowledge or experience. Using GRASP also decreased the decisional conflict 
facing professionals, through improving their confidence and satisfaction with their 
decisions. Using GRASP has also improved the efficiency of professionals in making 
their selection decisions, through decreasing the time needed to complete the decision-
making task. 
 
The GRASP framework represents a high-level approach to provide professionals 
with an evidence-based and comprehensive, yet simple and feasible, method to evaluate 
and select predictive tools. However, when professionals need further information, the 
framework detailed report provides them with the required details to support their 
decision making. The GRASP framework is not meant to be absolutely prescriptive. A 
lower grade tool could be preferred by a healthcare professional to improve clinical 
outcomes that are not supported by a higher grade one. It all depends on the objectives 
and priorities professionals are trying to achieve. More than one predictive tool could 
be endorsed, in clinical guidelines, each supported by its requirements and conditions 
of use and recommended for its most prominent outcomes of predictive performance or 
post-implementation impact on healthcare and clinical outcomes. 
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4.5. Study Limitations and Future Work 
 
Even though we received a large and sufficient number of 194 valid responses, 
the very low response rate of 5.9% could have been improved if potential participants 
were motivated by some incentives. They could have also been motivated if more 
support was provided through their organisations, which needs more resources to 
synchronise such efforts. For the sake of keeping the survey feasible, for most busy 
professionals, the number of questions was kept limited and the required time to 
complete the survey was kept in the range of 20 minutes. However, some of the 
participants showed their willingness to provide more detailed feedback, which could 
have been done through interviews for example, but this was out of the scope of the 
study and was not initially possible with the huge number of invited participants. The 
reduction in the decision-making duration of selecting predictive tools, while using 
GRASP, was statistically insignificant, due to the high variability and extreme statistical 
outliers; with and without GRASP. This could be explained by the fact that the Qualtrics 
platform of the survey measures the task completion duration by subtracting the time 
of loading the page from the time of pushing the Next button after completing the task, 
and not the actual time the participants spent active on the page, which is currently 
under development [73]. 
 
To enable professionals and clinical guideline developers to access detailed 
information, reported evidence and assigned grades of predictive tools, it is essential to 
implement the GRASP framework into an online platform. However, maintaining such 
grading system up to date is a challenging task, as this requires continuous updating of 
the predictive tools grading and assessments, when new published evidence becomes 
available. It is essential to use automated or semi-automated methods for searching and 
processing new information to keep the GRASP framework information, grades, and 
assessments updated. Finally, we recommend that the GRASP framework be utilised by 
working groups of professional organisations to grade predictive tools, in order to 
provide consistent results and increase reliability and credibility for end users. These 
professional organisations should also support disseminating such evidence-based 
information on predictive tools, in a similar way of announcing and disseminating new 
updates of clinical practice guidelines. 
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7. The Appendix 
 
7.1. The GRASP Framework Detailed Report 
 
Table 4: The GRASP Framework Detailed Report 
Name Name of predictive tool (report tool’s creators and year in the absence of a given name) 
Author Name of developer (first author or researcher) 
Country Country of development 
Year Year of development 
Category Diagnostic/Therapeutic/Prognostic/Preventive 
Intended use Specific aim/intended use of the predictive tool 
Intended user Type of practitioner intended to use the tool  
Clinical area Clinical specialty 
Target Population Target patient population and health care settings in which the tool is applied 
Target Outcome Event to be predicted (including prediction lead time if needed) 
Action Recommended action based on tool’s output 
Input source 
• Clinical (including Diagnostic, Genetic, Vital signs, Pathology) 
• Non-Clinical (including Healthcare Utilisation) 
Input type 
• Objective (Measured input; from electronic systems or clinical examination) 
• Subjective (Patient reported; history, checklist …etc.) 
Local context Is the tool developed using location-specific data? (e.g. life expectancy tables) 
Methodology Type of algorithm used for developing the tool (e.g. parametric/non-parametric) 
Internal Validation Method of internal validation 
Dedicated Support Name of the supporting/funding research networks, programs, or professional groups 
Endorsement Organisations endorsing the tool and/or clinical guidelines recommending its utilisation 
Automation Flag Automation status (manual/automated) 
Tool Citations Total citations of the tool 
Studies Number of studies reporting the tool 
Authors No Number of authors  
Sample Size Size of patient/record sample used in the development of the tool 
Journal Name Name of the journal that published the tool’s primary development study 
Journal Rank Impact factor of the journal 
Citation Index Calculated as: Average Annual Citations = number of citations/age of primary publication 
Publication Index Calculated as: Average Annual Studies = number of studies/age of primary publication 
Literature Index Calculated as: Citations and Publications = number of citations X number of studies 
Phase of 
Evaluation 
Level of Evidence Grade Evaluation Studies 
Phase C: 
 
Before 
implementation 
 
Is it possible? 
Insufficient 
internal validation 
C0 
Not tested for internal validity, insufficiently internally 
validated, or internal validation was insufficiently reported. 
Internal validation C3 
Tested for internally validity (reported calibration & 
discrimination; sensitivity, specificity, positive and negative 
predictive values & other predictive performance measures). 
External validation C2 Tested for external validity, using one external dataset. 
External validation 
multiple times 
C1 
Tested multiple times for external validity, using more than one 
external dataset. 
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Phase B:  
 
Planning for 
implementation  
 
Is it practicable? 
Usability B3 
Reported usability testing (tool effectiveness, efficiency, 
satisfaction, learnability, memorability, and minimizing errors). 
Potential effect B2 
Reported estimated potential effect on clinical effectiveness, 
patient safety or healthcare efficiency. 
Potential effect & 
Usability 
B1 Both potential effect and usability are reported. 
Phase A: 
 
After 
implementation: 
  
Is it desirable? 
Evaluation of post-
implementation 
impact on Clinical 
Effectiveness, 
Patient Safety or 
Healthcare 
Efficiency 
A3 
Based on subjective studies; e.g. the opinion of a respected 
authority, clinical experience, a descriptive study, or a report of 
an expert committee or panel. 
A2 
Based on observational studies; e.g. a well-designed cohort or 
case-control study. 
A1 
Based on experimental studies; properly designed, widely 
applied randomised/nonrandomised controlled trial. 
Assigned Grade Grade ABC/123 A1 A2 A3 B1 B2 B3 C1 C2 C3 
Direction of 
Evidence 
 Positive Evidence  Mixed Evidence Supporting Positive Conclusion 
 Negative Evidence  Mixed Evidence Supporting Negative Conclusion 
Justification 
Explains how the final grade is assigned based on evidence; which conclusions were taken into 
consideration, as positive evidence, and which were considered negative. 
References 
Details of studies that support the justification: phase of evaluation, level of evidence, direction 
of evidence, study type, study settings, methodology, results, findings and conclusions 
(highlighted according to the findings codes). 
Findings Codes Positive Findings / Negative Findings / Important Findings 
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7.2. The Paediatric and Adult Head Injury Predictive Tools 
 
Table 5: The GRASP Evidence-Based Summary of Paediatric Head Injury Predictive Tools 
Tool 
Tool Information 
Tool 
Grade 
Impact After 
Implementation 
Planning for 
Implementation 
Performance Before 
Implementation 
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A1 A2 A3 B1 B2 B3 C1 C2 C3 
PECARN USA 2009 886 24 A2  
 
  
 
 
 
 
 
CHALICE UK 2006 308 15 B2     
 
 
 
 
 
CATCH USA 2006 321 12 C1       
 
 
 
Palchak USA 2003 247 3 C2        
  
Atabaki USA 2008 111 1 C3         
 
Evidence 
Direction 
 Positive Evidence  Mixed Evidence Supporting Positive Conclusion 
 Negative Evidence  Mixed Evidence Supporting Negative Conclusion 
 
Table 6: The GRASP Evidence-Based Summary of Adult Head Injury Predictive Tools 
Tool 
Tool Information 
Tool 
Grade 
Impact After 
Implementation 
Planning for 
Implementation 
Performance Before 
Implementation 
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A1 A2 A3 B1 B2 B3 C1 C2 C3 
CCHR Canada 2001 1098 23 C1 
  
  
 
 
 
 
 
NOC  USA 2000 907 11 C1     
 
 
 
 
 
Miller USA 1997 210 2 C3        
  
KHR S Africa 2013 7 1 C3         
 
Ibanez Spain 2004 165 1 C0         
 
Evidence 
Direction 
 Positive Evidence  Mixed Evidence Supporting Positive Conclusion 
 Negative Evidence  Mixed Evidence Supporting Negative Conclusion 
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7.3. Statistical Tables and Figures 
 
Table 7: Gender Distribution of Participants 
Gender Count Percentage Cum 
Males 120 61.9% 61.9% 
Females 67 34.5% 96.4% 
Not Reported 7 3.6% 100.0% 
Total 194 100% 
 
 
Figure 3: Gender Distribution of Participants 
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Table 8: Age Group Distribution of Participants 
Age Group Count Percentage Cum 
25 – 34 years 23 11.9% 11.9% 
35 - 44 years 89 45.9% 57.7% 
45 - 54 years 49 25.3% 83.0% 
55 - 64 years 20 10.3% 93.3% 
65 - 74 years 7 3.6% 96.9% 
75 years or older 1 0.5% 97.4% 
Not Reported 5 2.6% 100.0% 
Total 194 100% 
Average Age 44.8 years 
 
 
 
Figure 4: Age Group Distribution of Participants 
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Table 9: Years of Experience Distribution of Participants 
Years of Experience Count Percentage Cum 
Less than 5 years 12 6.2% 6.2% 
05-09 years 29 14.9% 21.1% 
10-14 years 53 27.3% 48.5% 
15-19 years 32 16.5% 64.9% 
20-24 years 22 11.3% 76.3% 
25-29 years 19 9.8% 86.1% 
30-34 years 12 6.2% 92.3% 
35 years or more 10 5.2% 97.4% 
Not Reported 5 2.6% 100.0% 
Total 194 100% 
Average Age 16.7 years 
 
 
 
Figure 5: Years of Experience Distribution of Participants 
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Table 10: Role Distribution of Participants 
Clinical Role Count Percentage Cum 
Physician - Consultant 114 58.8% 58.8% 
Physician - Registrar 10 5.2% 63.9% 
Physician - Resident 6 3.1% 67.0% 
Nurse - Senior 13 6.7% 73.7% 
Nurse - Junior 0 0.0% 73.7% 
Other Healthcare 
professionals 
46 23.7% 97.4% 
Not Reported 5 2.6% 100.0% 
Total 194 100% 
 
 
 
Figure 6: Role Distribution of Participants 
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Table 11: Specialty Distribution of Participants 
Clinical Specialty Count Percentage Cum 
Emergency Medicine 94 48.5% 48.5% 
Other Specialties 95 49.0% 97.4% 
Not Reported 5 2.6% 100.0% 
Total 194 100% 
 
 
 
Figure 7: Specialty Distribution of Participants 
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Table 12: Participants are Familiar with Predictive Tools 
Familiar with Tools Count Percentage Cum 
Strongly Agree (code = 5) 47 24.2% 24.2% 
Somewhat Agree (code = 4) 61 31.4% 55.7% 
Neither Agree nor Disagree (code = 3) 18 9.3% 64.9% 
Somewhat Disagree (code = 2) 33 17.0% 82.0% 
Strongly Disagree (code = 1) 30 15.5% 97.4% 
Not Reported 5 2.6% 100.0% 
Total 194 100% 
Average Neither Agree nor Disagree (score = 3.33) 
 
 
Figure 8: Participants are Familiar with Predictive Tools 
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Table 13: Country Distribution of Participants 
SN Country Respondents Percent Cum 
1 United States 57 29.4% 29.4% 
2 Australia 23 11.9% 41.2% 
3 Italy 17 8.8% 50.0% 
4 Canada 11 5.7% 55.7% 
5 United Kingdom 11 5.7% 61.3% 
6 Germany 6 3.1% 64.4% 
7 Netherlands 5 2.6% 67.0% 
8 Switzerland 5 2.6% 69.6% 
9 Belgium 4 2.1% 71.6% 
10 Saudi Arabia 4 2.1% 73.7% 
11 Spain 4 2.1% 75.8% 
12 Sweden 4 2.1% 77.8% 
13 Brazil 3 1.5% 79.4% 
14 China 3 1.5% 80.9% 
15 Turkey 3 1.5% 82.5% 
16 Colombia 2 1.0% 83.5% 
17 India 2 1.0% 84.5% 
18 Japan 2 1.0% 85.6% 
19 Lebanon 2 1.0% 86.6% 
20 Lithuania 2 1.0% 87.6% 
21 Palestine 2 1.0% 88.7% 
22 Poland 2 1.0% 89.7% 
23 Portugal 2 1.0% 90.7% 
24 Taiwan 2 1.0% 91.8% 
25 Europe 6 3.1% 94.8% 
26 Asia 4 2.1% 96.9% 
27 Africa 3 1.5% 98.5% 
28 South America 3 1.5% 100.0% 
Total 194 100% 
 
 
Figure 9: Country Distribution of Participants 
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7.4. Survey Screenshots 
 
 
Section 1: The survey introduction 
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Section 2: Block 1: Paediatric Head Injury Predictive Tools With GRASP 
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Section 2: Block 2: Adult Head Injury Predictive Tools Without GRASP 
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Section 2: Block 3: Paediatric Head Injury Predictive Tools Without GRASP 
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Section 2: Block 4: Adult Head Injury Predictive Tools With GRASP 
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Section 3: GRASP System Usability Scale and Usefulness 
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Section 4: Participants’ Demographics 
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Section 5: Participants’ Feedback and Acknowledgment 
